Hologic WTA Tour Swings into Action Ahead of BNP Paribas Open
March 09 2022 - 8:00AM
Business Wire
- Players will be screened in Indian Wells on Hologic’s
state-of-the-art DXA technology, providing valuable health and
performance insights
- Partnership introduces new opportunities in the fight
against women’s cancers through expanded ACEing Cancer
program
Hologic and the WTA kicked off a multi-year partnership this
week with their first onsite activities at the BNP Paribas Open in
Indian Wells, launching a joint vision to achieve greater wellness
and equality for women. The Hologic WTA Tour was announced last
week when medical technology leader Hologic became the title
sponsor for the WTA, the global leader in women’s professional
sports.
In alignment with the WTA’s commitment to making athlete health
and wellness a top priority – and Hologic’s focus on improving
women’s health through early detection, diagnosis, and treatment –
the partnership will allow players to receive expanded and
specialized screenings.
In a first for WTA athletes, those competing in the BNP Paribas
Open will have the opportunity to undergo an evaluation with
Hologic’s Horizon® DXA system. The system provides detailed
analysis of bone density and body composition by looking at
multiple factors and segmented data on different parts of the
body.
“The DXA analysis gives players and their teams valuable
insights about body composition and bone health that can be used to
help inform health decisions as well as training and performance
strategies,” said Dr. Susan Harvey, Chief Medical Officer for
Hologic’s Breast and Skeletal Health Solutions Division. “We’re
thrilled to join forces with the WTA to provide elite athletes with
this world-class health and performance technology.”
The DXA scan will be added to the robust health screenings that
the WTA already provides for players, including evaluations with
specialists across dermatology, cardiology, orthopedics, internal
medicine, nutrition and hydration, and mental health.
WTA athletes will have access to physical exams at the
tournament grounds from March 7–10. With support from Hologic, the
WTA will now increase its frequency of preventive healthcare
screenings to empower the organizations’ joint mission of
championing women and making their health a top priority.
Kathleen Stroia, WTA SVP Performance Health, stated, “We are
excited to welcome the Hologic team and its leading medical
technology to the WTA’s players health and wellness experience.
This is just the beginning of what we can achieve through this
innovative partnership. Not only does this elevate the players’
immediate physical healthcare, but it also amplifies the greater
mission we share for promoting healthy practices and preventive
care, which positions us to globally champion women’s health.”
This is one example of what the two organizations hope to
accomplish together – providing broader opportunities for advocacy
and building awareness about screenings and early detection.
ACEing Cancer
The Hologic-WTA collaboration also will come to life this week
through WTA Charities’ ACEing Cancer program. Beginning at the BNP
Paribas Open and continuing at all WTA tournaments throughout the
season, Hologic will make contributions to WTA Charities’ ACEing
Cancer program, an initiative designed to raise awareness and
proceeds towards the fight against women’s cancers. WTA athletes
and legends of the game will participate in various ACEing Cancer
activities to help raise awareness of the need for early detection,
diagnosis, and treatment. The public can join the cause as well.
Learn more about ACEing Cancer.
The Hologic-WTA partnership begins at a pivotal moment when
health screenings are down for women across the world because of
the COVID pandemic. It’s more important than ever that women
prioritize their health – and one way to do that is through an
annual Well Woman visit. To learn more about the Well Woman exam,
visit ScreeningsForHer.com.
About the WTA:
Founded by Billie Jean King in 1973 on the principle of equal
opportunity, the WTA is the global leader in women’s professional
sports. The WTA is one of the world’s most recognizable and
high-profile sports organizations, consisting of more than 1600
players representing approximately 87 nations, all competing to
earn WTA rankings points and prestigious tournament titles. The
Hologic WTA Tour is annually comprised of around 50 events and four
Grand Slams, spanning six continents and nearly 30 countries and
regions with a global audience of over 900 million. Further
information on the WTA can be found at wtatennis.com.
About Hologic:
Hologic, Inc. is a global medical technology innovator primarily
focused on improving women’s health and well-being through early
detection and treatment. Its advancements include invention of the
world’s first commercial 3D mammography system to fight breast
cancer; leadership in testing for cervical cancer, sexually
transmitted infections, respiratory illnesses, and the virus that
causes COVID-19; and minimally invasive surgical technologies for
uterine fibroids and abnormal uterine bleeding. The company also
champions women through the Hologic Global Women’s Health Index,
which provides a science-backed data roadmap for improving women’s
well-being, and Project Health Equality, which elevates awareness,
research insights and access to quality care for underserved
women.
SOURCE: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220309005070/en/
Amy Binder, WTA, abinder@wtatennis.com Jessica Culbreath, WTA,
jculbreath@wtatennis.com Jane Mazur, Hologic,
jane.mazur@hologic.com
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Sep 2023 to Sep 2024